Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris global luxury conglomerate (EPA: MC) at ~€84.7B 2024 revenue; 75+ brands (Louis Vuitton, Dior, Hennessy, Sephora), named preferred buyer for Giorgio Armani (€10B+) after founder's Sept 2025 death, competing with Kering and Hermès.
LVMH Moët Hennessy Louis Vuitton SE is a Paris, France-based global luxury goods conglomerate — publicly traded on Euronext Paris (EPA: MC) and the world's largest luxury company by revenue — owning and managing 75+ prestige brands across Fashion & Leather Goods, Wines & Spirits, Perfumes & Cosmetics, Watches & Jewelry, and Selective Retailing through approximately 213,000 employees serving luxury consumers across 6 continents. LVMH's flagship brands include Louis Vuitton (the world's most valuable luxury brand), Christian Dior Couture, Moët & Chandon, Dom Pérignon, Hennessy cognac, Givenchy, Celine, Fendi, Bulgari, TAG Heuer, Hublot, Sephora, and DFS. In fiscal year 2024, LVMH reported revenue of approximately €84.7 billion, with the Fashion & Leather Goods segment (Louis Vuitton and Dior, ~40% of revenue) demonstrating resilience in a challenging global luxury environment characterized by post-pandemic demand normalization, Chinese luxury consumer caution, and currency headwinds. CEO and Chairman Bernard Arnault — the world's wealthiest individual — has built LVMH through decades of acquisitions of trophy luxury brands. LVMH's most significant strategic development for 2025-2026 is the preferred buyer designation for Giorgio Armani following the Italian fashion designer's death in September 2025 — with LVMH named in Armani's will as the preferred acquirer of the €10B+ Armani Group, with an initial 15% purchase within 18 months potentially leading to a full acquisition of one of the world's last independent luxury fashion houses.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.